Controlled double-blind trial of dazoxiben and nifedipine in the treatment of Raynaud's phenomenon

Moncada, 1979, Arachidonic acid metabolites and the interactions between platelets and blood vessel walls, N Engl J Med, 300, 1142, 10.1056/NEJM197905173002006 Clifford, 1980, Treatment of vasospastic disease with prostaglandin E1, Br Med J, 281, 1031, 10.1136/bmj.281.6247.1031 Belch, 1981, Successful treatment of Raynaud's phenomenon with prostacyclin, Thromb Haemost, 45, 255, 10.1055/s-0038-1650182 Vermyleu, 1981, Thromboxane synthetase inhibition as antithrombotic therapy, Lancet, I, 1073, 10.1016/S0140-6736(81)92241-8 Cowley, 1983, Effects of dazoxiben, an inhibitor of thromboxane synthetase on forearm vasoconstriction in response to cold stimulation, and on human blood vessel prostacyclin production, Br J Pharmacol, 15, 107, 10.1111/j.1365-2125.1983.tb02118.x Belch, 1983, Dazoxiben, a thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome: a double blind trial, Br J Pharmacol, 15, 113, 10.1111/j.1365-2125.1983.tb02119.x Rodeheffer, 1983, Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon, N Engl J Med, 308, 880, 10.1056/NEJM198304143081507 Smith, 1982, Controlled trial of nifedipine in the treatment of Raynaud's phenomenon, Lancet, II, 1299, 10.1016/S0140-6736(82)91508-2 Kahan, 1982, Etade controlee de la nifedipine dans le traitement du phenomene de Raynaud, Rev Rhum Mal Osteoartic, 49, 337 Nielson, 1982, Finger systolic pressures in upper extremity testing for cold sensitivity (Raynaud's phenomenon), 410 Nielson, 1978, Raynaud phenomena and finger systolic pressure during cooling, Scand J Clin Lab Invest, 38, 765, 10.3109/00365517809104885 Kahaleh, 1982, Elevated levels of circulating platelet aggregates and beta thromboglobulin in scleroderma, Ann Intern Med, 96, 610, 10.7326/0003-4819-96-5-610 Zahavia, 1980, Plasma exchange and platelet function in Raynaud's phenomenon, Thromb Res, 19, 85, 10.1016/0049-3848(80)90406-5 Bertele, 1983, Platelet thromboxane synthetase inhibitors with low doses of aspirin, Science, 220, 517, 10.1126/science.6682245 Levy-Toledano, 1982, Human platelet activation in the absence of aggregation: a calcium dependent phenomenon independent of thromboxane formation, Blood, 59, 1078, 10.1182/blood.V59.5.1078.1078 Coffman, 1979, Vasodilator drugs in peripheral vascular disease, N Engl J Med, 300, 713, 10.1056/NEJM197903293001305 Young, 1983, Sample size nomograms for interpreting negative clinical studies, Ann Intern Med, 99, 248, 10.7326/0003-4819-99-2-248 Ebner, 1976, Haemodynamics, therapeutic mechanism of action and clinical findings of adalat use based on worldwide clinical trials, 283